Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Sensor‐based wearable system for the detection and automatic treatment of nocturnal hypoglycaemia

View through CrossRef
Diabetic patients are prone to daily and severe health‐related risks, namely hyper and hypoglycaemia. Hypoglycaemia phenomenon happens when the glucose level in patient's blood is lower than a well‐determined sill. It may induce serious impacts, such as functional brain failure or even the death. Hypoglycaemia is especially dangerous when it occurs during the night while the patient is asleep because it becomes difficult to be detected by the patient itself or other persons around him. While all existing sensor‐based solutions are detection‐only driven, the proposed solution goes beyond and attempts to treat autonomously, and at low cost, the nocturnal hypoglycaemia. The presented system detects the nocturnal hypoglycaemia phenomenon based on accelerated heart‐rate symptom and a progressive detection algorithm. The system treats then the detected nocturnal hypoglycaemia throughout safe and automatic injection of glucagon.
Title: Sensor‐based wearable system for the detection and automatic treatment of nocturnal hypoglycaemia
Description:
Diabetic patients are prone to daily and severe health‐related risks, namely hyper and hypoglycaemia.
Hypoglycaemia phenomenon happens when the glucose level in patient's blood is lower than a well‐determined sill.
It may induce serious impacts, such as functional brain failure or even the death.
Hypoglycaemia is especially dangerous when it occurs during the night while the patient is asleep because it becomes difficult to be detected by the patient itself or other persons around him.
While all existing sensor‐based solutions are detection‐only driven, the proposed solution goes beyond and attempts to treat autonomously, and at low cost, the nocturnal hypoglycaemia.
The presented system detects the nocturnal hypoglycaemia phenomenon based on accelerated heart‐rate symptom and a progressive detection algorithm.
The system treats then the detected nocturnal hypoglycaemia throughout safe and automatic injection of glucagon.

Related Results

Dynamic stochastic modeling for inertial sensors
Dynamic stochastic modeling for inertial sensors
Es ampliamente conocido que los modelos de error para sensores inerciales tienen dos componentes: El primero es un componente determinista que normalmente es calibrado por el fabri...
Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
Sirolimus therapy in a child with partially diazoxide-responsive hyperinsulinaemic hypoglycaemia
Summary Hyperinsulinaemic hypoglycaemia (HH), which causes persistent neonatal hypoglycaemia, can result in neurological damage and it’s mana...
Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures
Frequency of Hypoglycaemia after Different Bariatric Surgical Procedures
<b><i>Objectives:</i></b> The frequency of postprandial hypoglycaemia after different operative procedures of bariatric surgery (BS) is unknown, although th...
Vulnerable Hours of the Day for Iatrogenic Hypoglycaemia
Vulnerable Hours of the Day for Iatrogenic Hypoglycaemia
Background: Normal or near normal glucose to prevent and hopefully reverse diabetic complications is difficult to attain in the real world due to drug-induced hypoglycaemia. In thi...
Hypoglycaemia begets hypoglycaemia
Hypoglycaemia begets hypoglycaemia
Drug-induced (insulin/insulin secretagogue) hypoglycaemia is the most common cause of hypoglycaemia particularly in the elderly. It is estimated that hypoglycaemia of any severity ...
Contribution of Transcutaneous P CO 2 in Obesity Hypoventilation Syndrome
Contribution of Transcutaneous P CO 2 in Obesity Hypoventilation Syndrome
BACKGROUND: Increasing numbers of patients have obesity-hypoventilation syndrome (OHS) because of the increasing prevalence of obesity. T...
Peptide receptor radionuclide therapy in malignant insulinoma
Peptide receptor radionuclide therapy in malignant insulinoma
Abstract The management of malignant insulinoma (MI) presents dual management challenges of hypoglycaemia and tumour control. This study aims to analyse long-term...

Back to Top